All Stories

  1. Identifying and Evaluating Flavonoids as Potential Inhibitors of SARS-CoV-2 Main Protease (Mpro/3CL) Through Docking and Molecular Dynamics
  2. Reduced socs2 expression and elevated IL-4/IL-23 levels in multiple sclerosis patients: Implications for immune dysregulation
  3. Programmed -1 ribosomal frameshifting in SARS-CoV-2: molecular mechanisms and implications for antiviral targeting
  4. Gamma Radiation Induces an Interferon-Independent Antiviral Activity in Human Macrophages
  5. Efectividad de una Intervención Educativa Basada en Simulación para Mejorar la Identificación de Factores de Riesgo de hemorragia Obstétrica Postparto en Personal Médico y de Enfermería Becarios
  6. Quantification of Zika virus using a colloidal gold nanoparticle-based immunosensor and Fourier-transform infrared spectroscopy
  7. Development and validation of a dynamic light scattering-based method for viral quantification: A straightforward protocol for a demanding task
  8. Unlocking the Gate: Keys to Understanding Zika Virus Interactions with Human Cell Receptors
  9. Step-by-step protocol: IAV titration by Dynamic Light Scattering v1
  10. Reduced socs2 expression and elevated IL-4/IL-23 levels in multiple sclerosis patients: Implications for immune dysregulation
  11. Role of the NLRP3 inflammasome in the immunopathogenesis of flaviviruses
  12. Advances in the Elimination of Viral Hepatitis in Mexico: A Local Perspective on the Global Initiative
  13. Baloxavir Resistance Markers in Influenza A and B Viruses in the Americas
  14. Non-Analog Compounds to Sialic Acid as Inhibitors of Influenza Virus Neuraminidase: An Underexplored Approach for Novel Antivirals―Systematic Review
  15. Detection of Zika Virus by the Development of a Colloidal Gold Nanoparticle-Based Immunosensor
  16. Comparative Review of the State of the Art in Research on the Porcine Epidemic Diarrhea Virus and SARS-CoV-2, Scope of Knowledge between Coronaviruses
  17. Hepatitis B Virus and Hepatocellular Cancer: Molecular Mechanisms and Breakthroughs in Therapeutic Approaches
  18. Hepatitis C Virus and Hepatocellular Cancer: Molecular Mechanisms and Advancements in Treatment
  19. Antiviral resistance in influenza viruses
  20. Age and Comorbidities as Risk Factors for Severe COVID-19 in Mexico, before, during and after Massive Vaccination
  21. Donated Blood Screening for HIV, HCV and HBV by ID-NAT and the Residual Risk of Iatrogenic Transmission in a Tertiary Care Hospital Blood Bank in Puebla, Mexico
  22. Chronic Comorbidities in Middle Aged Patients Contribute to Ineffective Emergency Hematopoiesis in Covid-19 Fatal Outcomes
  23. SARS-CoV-2: basic concepts, origin and treatment advances
  24. Response to Article “Serum Levels of Galectin-9 are Increased in Cervical Cancer Patients and are Higher in Advanced Clinical Stages” [Response to Letter]
  25. Serum Levels of Galectin-9 are Increased in Cervical Cancer Patients and are Higher in Advanced Clinical Stages
  26. Decrease in COVID-19 adverse outcomes in adults during the Delta and Omicron SARS-CoV-2 waves, after vaccination in Mexico
  27. In silicotesting of flavonoids as potential inhibitors of protease and helicase domains of dengue and Zika viruses
  28. Neuropathological Aspects of SARS-CoV-2 Infection: Significance for Both Alzheimer’s and Parkinson’s Disease
  29. Predicted 3D model of the M protein of Porcine Epidemic Diarrhea Virus and analysis of its immunogenic potential
  30. Salud porcina: historia, retos y perspectivas
  31. Effectiveness, tolerability and safety of Direct Acting Antivirals in Mexican individuals with Hepatitis C virus genotype-1 and previous pegylated interferon and ribavirin therapy
  32. Serum Th17 and TNF-α distinguish between patients with occult hepatitis B infection, chronic hepatitis B infection and healthy individuals
  33. Estudio de casos confirmados de brucelosis humana en Puebla, México
  34. A comprehensive update of the status of hepatitis C virus (HCV) infection in Mexico—A systematic review and meta-analysis (2008–2019)
  35. The role of metabolic comorbidity in COVID-19 mortality of middle-aged adults. The case of Mexico
  36. Glycogene expression profiles from a HaCaT cell line stably transfected with HPV16 E5 oncogene
  37. Immunoinformatics approach for predicting epitopes in HN and F proteins of Porcine rubulavirus
  38. Histone H3K9 and H3K14 acetylation at the promoter of the LGALS9 gene is associated with mRNA levels in cervical cancer cells
  39. Five Novel Non-Sialic Acid-Like Scaffolds Inhibit In Vitro H1N1 and H5N2 Neuraminidase Activity of Influenza a Virus
  40. Primary Dengue Infection in Patients Requiring Hospitalization During an Outbreak in a Low Incidence Mexican Region
  41. Identification and characterization of the V3 promoter of the ST3GAL4 gene
  42. Differential Transcription of SOCS5 and SOCS7 in Multiple Sclerosis Patients Treated with Interferon Beta or Glatiramer Acetate
  43. Antiviral and immunomodulatory effects of polyphenols on macrophages infected with dengue virus serotypes 2 and 3 enhanced or not with antibodies
  44. Effectiveness of PCR primers for the detection of occult hepatitis B virus infection in Mexican patients
  45. Drug resistance in influenza viruses from Mexico
  46. Glycogene expression profiles based on microarray data from cervical carcinoma HeLa cells with partially silenced E6 and E7 HPV oncogenes
  47. Diabetic ketoacidosis complicated by supraventricular tachycardia in a young adult: a case report
  48. Expression analysis of ST3GAL4 transcripts in cervical cancer cells
  49. Taraxacum officinale and Urtica dioica extracts inhibit dengue virus serotype 2 replication in vitro
  50. Neuraminidase activity of blue eye disease porcine rubulavirus: Specificity, affinity and inhibition studies
  51. Polymorphisms in the hepatitis C virus core and its association with development of hepatocellular carcinoma
  52. Heterologous Expression of Laccase (LACP83) of Pleurotus ostreatus
  53. Hepatic mobilization of zinc after an experimental surgery, and its relationship with inflammatory cytokines release, and expression of metallothionein and Zip14 transporter
  54. Prevalence of Serologic Hepatitis B Markers in Blood Donors From Puebla, Mexico: The Association of Relatively High Levels of Anti-Core Antibodies With the Detection of Surface Antigen and Genomic DNA
  55. Hepatitis B surface antibodies in medical students from a public university in Puebla, Mexico
  56. Production of an enzymatically active and immunogenic form of ectodomain of Porcine rubulavirus hemagglutinin-neuraminidase in the yeast Pichia pastoris
  57. Upregulation of the Suppressors of Cytokine Signaling 1 and 3 Is Associated with Arrest of Phosphorylated-STAT1 Nuclear Importation and Reduced Innate Response in Denguevirus-Infected Macrophages
  58. Interferon lambda inhibits dengue virus replication in epithelial cells
  59. Chemoenzymatic Syntheses of Sialylated Oligosaccharides Containing C5-Modified Neuraminic Acids for Dual Inhibition of Hemagglutinins and Neuraminidases
  60. Human papillomavirus infections in Mexican women with normal cytology, precancerous lesions, and cervical cancer: Type-specific prevalence and HPV coinfections
  61. Quantitative analysis of the suppressors of cytokine signaling 1 and 3 in peripheral blood leukocytes of patients with multiple sclerosis
  62. Transfection of influenza A virus nuclear export protein induces the expression of tumor necrosis factor alpha
  63. Detection of hepatitis C virus RNA in saliva of patients with active infection not associated with periodontal or liver disease severity
  64. Promoter Polymorphisms of ST3GAL4 and ST6GAL1 Genes and Associations with Risk of Premalignant and Malignant Lesions of the Cervix
  65. Sialyl Lewis x expression in cervical scrapes of premalignant lesions
  66. Characterization of P1 promoter activity of the β-galactoside α2,6sialyltransferase I gene (siat 1) in cervical and hepatic cancer cell lines
  67. Modulation of apoptosis by V protein mumps virus
  68. Los problemas de la nomenclatura de virus
  69. Interaction of mumps virus V protein variants with STAT1-STAT2 heterodimer: experimental and theoretical studies
  70. Human papillomavirus infection in women from Tlaxcala, Mexico
  71. Increased expression of sialic acid in cervical biopsies with squamous intraepithelial lesions
  72. Hepatitis C virus infection in blood donors from the state of Puebla, Mexico
  73. Quantitative analysis of interferon alpha receptor subunit 1 and suppressor of cytokine signaling 1 gene transcription in blood cells of patients with chronic hepatitis C
  74. Prevalence of human papillomavirus genotypes in women from a rural region of Puebla, Mexico
  75. Structure-function analysis of two variants of mumps virus hemagglutinin-neuraminidase protein
  76. Molecular characterization of the hemagglutinin-neuraminidase gene of porcine rubulavirus isolates associated with neurological disorders in fattening and adult pigs
  77. Prevalence of hepatitis C virus in the Mexican population: A systematic review
  78. Biochemical characterization and structural prediction of a novel cytosolic leucyl aminopeptidase of the M17 family from Schizosaccharomyces pombe
  79. Differential sensitivity to interferon influences the replication and transcription of Urabe AM9 mumps virus variants in nerve cells
  80. Amino acid change 335 E to K affects the sialic-acid-binding and neuraminidase activities of Urabe AM9 mumps virus hemagglutinin–neuraminidase glycoprotein
  81. Two clones obtained from Urabe AM9 mumps virus vaccine differ in their replicative efficiency in neuroblastoma cells
  82. Purification of the Porcine rubulavirus attachment protein by liquid isoelectric focusing
  83. Purification and characterization of the Hemagglutinin-Neuraminidase of porcine rubulavirus LPMV